Although the functions of most S100 proteins are still poorly characterized, recent studies indicate that some have pleiotropic pathological functions in NAFLD/NASH fostering progression of these metabolic disorders toward severe stages and cancer development. The gene discussed is S100A1; the disease is cancer.